What To Know
- The Company aims to revolutionize early-detection healthcare by deploying a global medical imaging infrastructure at an affordable price-per-scan service model to maximize the availability and accessibility of medical imaging to all socio-economic communities.
- As a strategic investor, The Yozma Group Asia is eager to make a global success case of Asian and Israeli collaboration by merging Nanox innovative technology and Korea's outstanding manufacturing knowhow.
Nanox Imaging (Nanox) today reports they have secured over $100M in crossover equity investments. The news was announced today. Israeli-based A-Labs Advisory and Finance Ltd. was the lead advisor to the financing round.
The funds raised are planned to primarily support the rollout of the Nanox.ARC deployments worldwide.
The financing round was initiated in November 2019 and was delayed in closing due to the COVID-19 pandemic. Since November 2019, Nanox has signed agreements for the deployment of thousands of units of the Nanox System, its innovative medical imaging system, and diagnostics services in eleven global regions. The Company aims to revolutionize early-detection healthcare by deploying a global medical imaging infrastructure at an affordable price-per-scan service model to maximize the availability and accessibility of medical imaging to all socio-economic communities.
“It is easy to say that we are aiming to change the world,” says Ran Poliakine, Founder and Chief Executive Officer of Nanox. “The main challenge with such statements is always the execution. We have a bold vision to increase the early detection of medical conditions that are discoverable by X-ray. We are actively working to deploy a global medical imaging service infrastructure that may turn this dream into reality. We cannot do it without partners and investors who share our vision and support our plan. I thank our investors at SK Telecom, Foxconn, Industrial Alliance and Yozma Korea for their faith and trust in the Nanox team and vision.”
“The innovative approach of preventive healthcare and the MEMs X-ray source have driven us, The Yozma Group Asia, to invest in Nanox. Potentially reduced radiation exposure and lowered cost can set a new standard of regular health checkups,” says Wonjae Lee, Head of Asia Pacific and Managing Partner of Yozma Group. “I’m honored to be a part of the Nanox project not only because its technology is groundbreaking and contributing to mankind, but also because it’s the best example of multinational collaboration. As a strategic investor, The Yozma Group Asia is eager to make a global success case of Asian and Israeli collaboration by merging Nanox innovative technology and Korea’s outstanding manufacturing knowhow.”